AbstractObjectivesThis case report aims to describe the effects of craniosacral therapy and acupuncture in a patient with chronic migraine.
MethodsA 33-year-old man with chronic migraine was treated with 20 sessions of craniosacral therapy and acupuncture for 8 weeks. The number of migraine and headache days were monitored every month. The pain intensity of headache was measured on the visual analog scale (VAS). Korean Headache Impact Test-6 (HIT-6) and Migraine Specific Quality of Life (MSQoL) were also used.
ResultsThe number of headache days per month reduced from 28 to 7 after 8 weeks of treatment and to 3 after 3 months of treatment. The pain intensity of headache based on VAS reduced from 7.5 to 3 after 8 weeks and further to < 1 after 3 months of treatment. Furthermore, the patient’s HIT-6 and MSQoL scores improved during the treatment period, which was maintained or further improved at the 3 month follow-up. No side effects were observed during or after the treatment.
참고문헌1. Arnold M.(2018). Headache classification committee of the International Headache Society (IHS): The international classification of headache disorders. 3rd edition. Cephalalgia. 38:(1. p. 1-211. 10.11770333102417738202
2. An, H.K., Do, J.K., Park, J.Y., Han, C.H., & Lee, D.K. (2007). Comparisons of life quality between chronic and episodic migraine patients. Journal of the Korean Neurological Association, 25(3), 293-297.
3. Hovaguimian, A., & Roth, J. (2022). Management of chronic migraine. British medical journal, 379, e067670. 10.1136/bmj-2021-067670
  4. Kwak, M.J., Han, Y.H., Geum, J.H., Park, S.H., Woo, H.J., Ha, W.B., & Lee, J.H. (2022). Trends in domestic and international clinical research of craniosacral therapy. Scoping Review Journal of Korean Medicine Rehabilitation, 32(3), 13-27. 10.18325/jkmr.2022.32.3.13
5. Arnadottir, T.S., & Sigurdardottir, A.K. (2013). Is craniosacral therapy effective for migraine? Tested with HIT-6 Questionnaire, 19(1), 11-14. 10.1016/j.ctcp.2012.09.003
6. Haller, H., Lauche, R., Sundberg, T., Dobos, G., & Cramer, H. (2020). Craniosacral therapy for chronic pain: a systematic review and meta-analysis of randomized controlled trials. BMC Musculoskeletal Disorders, 21(1), 1. 10.1186/s12891-019-3017-y1471-2474.
7. Upledger J.E., Vrendevoogd J.D.(1983). Craniosacral therapy. 3rd ed. Seattle. Eastland Press.
8. Blumenfeld, A.M., Kaur, G., Mahajan, A., Shukla, H., Sommer, K., Tung, A., & Knievel, K.L. (2022). Effectiveness and safety of chronic migraine preventive treatments: A Systematic Literature Review. Pain and Therapy, 12(1), 251-274. 10.1007/s40122-022-00452-3
 9. Jensen, M.P., Chen, C., & Brugger, A.M. (2003). Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. Journal of Pain, 4(7), 407-414. 10.1016/s1526-5900(03)00716-8
10. Kosinski, M., Bayliss, M.S., Bjorner, J.B., Ware, J.E., Garber, W.H., Batenhorst, A., Cady, R., Dahlöf, C.G.H., Dowson, A., & Tepper, S. (2003). A six-item short-form survey for measuring headache impact: the HIT-6. Quality of life research, 12(8), 963-974. 10.1023/A:1026119331193
11. Chu, M.K., Im, H.J., Ju, Y.S., Yu, K.H., Ma, H.I., Kim, Y.J., Kim, J.Y., & Lee, B.C. (2009). Validity and reliability assessment of Korean headache impact test-6 (HIT-6). Journal of the Korean Neurological Association, 27(1), 1-6.
12. Lipton, R.B., Stewart, W.F., Sawyer, J., & Edmeads, J.G. (2001). Clinical utility of an instrument assessing migraine disability:the Migraine Disability Assessment(MIDAS) questionnaire. Headache, 41(9), 854-861.
13. Khara, M.S., Marianne, S.R., Werner, J.B., Suzanne, N.C., Rose, G., Gordon, F.M., Arnoldas, G.E., & Marek, J.G. (2010). HIT-6 and MIDAS as measures of headache disability in a headache referral population. Headache, 50(3), 383-395. 10.1111/j.1526-4610.2009
14. Wagner, T.H., Patrick, D.L., Galer, B.S., & Berzon, R.A. (1996). A new instrument to assess the long-term quality of life effects from migraine: development and psychometric testing of the MSQOL. Headache, 36(8), 484-492. 10.1046/j.1526-4610.1996.3608484.x
15. Moon, H.S., Chung, C.S., Lee, H.S., Park, H.S., Kim, S.W., & Woo, H.W. (2003). The reliability and validity of the migraine-specific quality of life questionnaire for Korean migraine suffers. Journal of the Korean Neurological Association, 21(2), 146-155.
16. Moon, H.S. (2018). Comprehensive review and update on chronic migraine. Journal of Korean American Medical Association, 61(5), 314-322. 10.5124/jkma.2018.61.5.314
17. Ishii, R., Schwedt, T.J., Dumkrieger, G., Lalvani, N., Craven, A., Goadsby, P.J., Lipton, R.B., Olesen, J., Silberstein, S.D., Burish, M.J., & Dodick, D.W. (2021). Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency. Headache, 61(7), 992-1003. 10.1111/head.14154
18. Sauro, K.M., Rose, M.S., Becker, W.J., Christie, S.N., Giammarco, R., Mackie, G.F., Eloff, A.G., & Gawel, M.J. (2010). HIT-6 and MIDAS as measures of headache disability in a headache referral population. Headache, 50(3), 383-395. 10.1111/j.1526-4610.2009.01544.x
19. Zhang, N., Houle, T., Hindiyeh, N., & Aurora, S.K. (2020). Systematic review: acupuncture vs standard pharmacological therapy for migraine prevention. Headache, 60(2), 309-317. 10.1111/head.13723
20. Lee, S.J., Lee, S.H., Heo, I., Hwang, E.H., Lim, H.H., & Song, Y.K. (2020). Chuna craniosacral therapy for headache: a systematic review and meta analysis. The Journal of Korea CHUNA Manual Medicine for Spine & Nerves, 15(1), 35-48. 10.30581/jkcmm.2020.15.1.35
|
|
|||||||||||||||||||||||||||||||||
|
|||||
PDF Links
Full text via DOI
PubReader
Download Citation 
Print 
